Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000710947 | SCV000841261 | uncertain significance | not provided | 2017-12-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710947 | SCV000892549 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000796725 | SCV000936250 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710947 | SCV001815015 | likely benign | not provided | 2020-04-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31731261) |
Ambry Genetics | RCV002325440 | SCV002610193 | likely benign | Inborn genetic diseases | 2019-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |